GlassScriptPhysician profile
Victor Putz
NPI 1154902286
$3,935.49
in general payments reported to CMS, 2019-2025
21 companies · $2,136 in 2025
The $2,136 reported for 2025 was more than what 84% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $15.41 · 2024: $1,784 · 2025: $2,136.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,122 · Travel and Lodging: $798.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,121.99 |
| Travel and Lodging | $798.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,488.20 | 2024-2025 | Prostep, Prostep Mica, Ortholoc 3di Crosscheck |
| Organogenesis INC. | $1,008.49 | 2024-2025 | Puraply Wound Matrix, Via Matrix, Cygnus Dual |
| Kerecis Limited | $179.30 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Depuy Synthes Sales INC. | $177.06 | 2024-2025 | Na, N/A |
| Inari Medical, INC. | $173.90 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Smith+Nephew, INC. | $156.28 | 2025 | Collagenase Santyl, Grafix, Regranex |
| Zak Ortho | $102.27 | 2025 | |
| Abbvie INC. | $95.37 | 2024 | |
| Convatec INC. | $93.22 | 2024-2025 | |
| Mimedx Group, INC. | $72.09 | 2024-2025 | |
| Paragon 28, INC. | $57.00 | 2024 | Phantom Metatarsal Shortening |
| Amgen INC. | $44.06 | 2025 | Krystexxa |
| Surgenex LLC | $40.92 | 2025 | Ardeograft, Renograft, Pellograft |
| Paratek Pharmaceuticals, INC. | $37.33 | 2024-2025 | Nuzyra |
| Reprise Biomedical, INC. | $36.16 | 2025 | Miro3d |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $34.15 | 2024 | Senza |
| Tactile Systems Technology INC | $29.12 | 2025 | Flexitouch Plus, Nimbl |
| Solventum Corporation | $26.43 | 2025 | Activ.A.C., V.A.C. Dermatac, Promogran Prisma |
| Treace Medical Concepts, INC. | $25.44 | 2025 | |
| Pinnacle, INC | $23.69 | 2024 | |
| Cashflow Solutions, LLC | $19.60 | 2025 | Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White, Pcd-51 731a (US) - White |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Victor Putz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.